Article
Risk stratification by somatic mutation burden in Ewing sarcoma
2 Jan 2019
Abstract excerpt
BACKGROUND: Up to one-third of patients with localized Ewing sarcoma (ES) develop recurrent disease, but current biomarkers do not accurately identify this high-risk group. Therefore, the objective of this study was to determine the utility of mutational burden in predicting outcomes in patients with localized ES. METHODS: Clinical and genomic data from 99 patients with ES, of whom 63 had localized disease at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
